+44 (0) 1698 534002

Contact

About Us
- - About BioAscent
- - Board
- - Management Team
- - Scientific Team
- - Awards
- - Testimonials
- - Our Values

Integrated Drug Discovery
- - Overview
- - Integrated drug discovery projects
- - Biochemical, Biophysical & Cellular Assay Development
- - Target analysis & bespoke screening strategies
- - Compound Screening
- - Surface Plasmon Resonance (SPR) & Biophysics
- - In Silico Discovery and Data Analysis
- - Physicochemical Profiling & DMPK
- - Medicinal & Synthetic Chemistry
- - External library selection & sourcing
- - In-house Diversity and Fragment Libraries

Compound Management

Publications & Case Studies
- - Case Studies
- - Publications

News & Events
- - News
- - Events

Careers

News

Drug Discovery Open Innovation: Maximising Diversity of Shared Compound Collections

08 October 2014

Considering embarking on an innovation-driven collaboration involving your compound collection?— How can you be sure you...

BioAscent on front cover of EBR Journal

08 October 2014

We’re excited that our lab automation features on the front cover of this month’s European Biopharmaceutical Review.

Compound Collection Sharing: A New Model of Drug Discovery Innovation

06 April 2014

The sharing of corporate compound collections was until recently very challenging.However last year’s successful creatio...

BioAscent is Compound Management “Centre of Excellence” for IMI European Lead Factory

01 January 2013

BioAscent have been selected as the Compound Logistics “Centre of Excellence” for the IMI European Lead Factory (ELF), a...

Previous
1
2
3
4
5
6
7
8
9

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.